136 related articles for article (PubMed ID: 9871777)
1. Novel constrained CCK-B dipeptoid antagonists derived from pipecolic acid.
Bellier B; Da Nascimento S; Meudal H; Gincel E; Roques BP; Garbay C
Bioorg Med Chem Lett; 1998 Jun; 8(11):1419-24. PubMed ID: 9871777
[TBL] [Abstract][Full Text] [Related]
2. Structure-based design of new constrained cyclic agonists of the cholecystokinin CCK-B receptor.
Blommaert AG; Dhôtel H; Ducos B; Durieux C; Goudreau N; Bado A; Garbay C; Roques BP
J Med Chem; 1997 Feb; 40(5):647-58. PubMed ID: 9057851
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and biological properties of new constrained CCK-B antagonists: discrimination of two affinity states of the CCK-B receptor on transfected CHO cells.
Bellier B; McCort-Tranchepain I; Ducos B; Danascimento S; Meudal H; Noble F; Garbay C; Roques BP
J Med Chem; 1997 Nov; 40(24):3947-56. PubMed ID: 9397175
[TBL] [Abstract][Full Text] [Related]
4. beta-Turned dipeptoids as potent and selective CCK(1) receptor antagonists.
Martín-Martínez M; De La Figuera N; Latorre M; Herranz R; García-López MT; Cenarruzabeitia E; Del Río J; González-Muñiz R
J Med Chem; 2000 Oct; 43(20):3770-7. PubMed ID: 11020292
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and SAR of new 5-phenyl-3-ureido-1,5-benzodiazepines as cholecystokinin-B receptor antagonists.
Ursini A; Capelli AM; Carr RA; Cassarà P; Corsi M; Curcuruto O; Curotto G; Dal Cin M; Davalli S; Donati D; Feriani A; Finch H; Finizia G; Gaviraghi G; Marien M; Pentassuglia G; Polinelli S; Ratti E; Reggiani AM; Tarzia G; Tedesco G; Tranquillini ME; Trist DG; Van Amsterdam FT
J Med Chem; 2000 Oct; 43(20):3596-613. PubMed ID: 11020274
[TBL] [Abstract][Full Text] [Related]
6. CCK(2) receptor antagonists containing the conformationally constrained phenylalanine derivatives, including the new amino acid Xic.
Gibson SE; Guillo N; Jones JO; Buck IM; Kalindjian SB; Roberts S; Tozer MJ
Eur J Med Chem; 2002 May; 37(5):379-89. PubMed ID: 12008052
[TBL] [Abstract][Full Text] [Related]
7. The use of topographical constraints in receptor mapping: investigation of the topographical requirements of the tryptophan 30 residue for receptor binding of Asp-Tyr-D-Phe-Gly-Trp-(N-Me)Nle-Asp-Phe-NH2 (SNF 9007), a cholecystokinin (26-33) analogue that binds to both CCK-B and delta-opioid receptors.
Boteju LW; Nikiforovich GV; Haskell-Luevano C; Fang SN; Zalewska T; Stropova D; Yamamura HI; Hruby VJ
J Med Chem; 1996 Sep; 39(20):4120-4. PubMed ID: 8831778
[TBL] [Abstract][Full Text] [Related]
8. Conformationally restricted analogues of the potent CCK-B antagonist CI-988.
Higginbottom M; Hill DR; Horwell DC; Mostafai E; Suman-Chauhan N; Roberts E
Bioorg Med Chem; 1993 Sep; 1(3):209-17. PubMed ID: 8081854
[TBL] [Abstract][Full Text] [Related]
9. Development of peptide 3D structure mimetics: rational design of novel peptoid cholecystokinin receptor antagonists.
Low CM; Black JW; Broughton HB; Buck IM; Davies JM; Dunstone DJ; Hull RA; Kalindjian SB; McDonald IM; Pether MJ; Shankley NP; Steel KI
J Med Chem; 2000 Sep; 43(19):3505-17. PubMed ID: 11000005
[TBL] [Abstract][Full Text] [Related]
10. Dual CCK-A and CCK-B receptor antagonists (II). Preparation and structure activity relationships of 5-alkyl-9-methyl-1,4-benzodiazepines and discovery of FR208419.
Tabuchi S; Ito H; Sogabe H; Kuno M; Kinoshita T; Katumi I; Yamamoto N; Mitsui H; Satoh Y
Chem Pharm Bull (Tokyo); 2000 Jan; 48(1):1-15. PubMed ID: 10705468
[TBL] [Abstract][Full Text] [Related]
11. Replacement of glycine with dicarbonyl and related moieties in analogues of the C-terminal pentapeptide of cholecystokinin: CCK(2) agonists displaying a novel binding mode.
Bellier B; Million ME; DaNascimento S; Meudal H; Kellou S; Maigret B; Garbay C
J Med Chem; 2000 Oct; 43(20):3614-23. PubMed ID: 11020275
[TBL] [Abstract][Full Text] [Related]
12. Novel glutamic acid derived cholecystokinin receptor ligands.
Freidinger RM; Whitter WL; Gould NP; Holloway MK; Chang RS; Lotti VJ
J Med Chem; 1990 Feb; 33(2):591-5. PubMed ID: 2299627
[TBL] [Abstract][Full Text] [Related]
13. Relationship between dihedral angles of N1 and C9 substituents in 1,4-benzodiazepines and dual cholecystokinin-A and -B antagonistic activities.
Tabuchi S; Nakanishi I; Satoh Y
Bioorg Med Chem Lett; 1998 Jun; 8(12):1449-54. PubMed ID: 9873368
[TBL] [Abstract][Full Text] [Related]
14. Species specificity of pharmacological characteristics of CCK-B receptors.
Kuwahara T; Kudoh T; Nakano A; Yoshizaki H; Takamiya M; Nagase H; Arisawa M
Neurosci Lett; 1993 Aug; 158(1):1-4. PubMed ID: 8233061
[TBL] [Abstract][Full Text] [Related]
15. Development of 1,4-benzodiazepine cholecystokinin type B antagonists.
Bock MG; DiPardo RM; Evans BE; Rittle KE; Whitter WL; Garsky VM; Gilbert KF; Leighton JL; Carson KL; Mellin EC
J Med Chem; 1993 Dec; 36(26):4276-92. PubMed ID: 8277510
[TBL] [Abstract][Full Text] [Related]
16. Anthranilic acid derivatives: a new class of non-peptide CCK1 receptor antagonists.
Varnavas A; Lassiani L; Valenta V; Berti F; Mennuni L; Makovec F
Bioorg Med Chem; 2003 Mar; 11(5):741-51. PubMed ID: 12538004
[TBL] [Abstract][Full Text] [Related]
17. Highly constrained dipeptoid analogues containing a type II' beta-turn mimic as novel and selective CCK-A receptor ligands.
de la Figuera N; Martín-Martínez M; Herranz R; García-López MT; Latorre M; Cenarruzabeitia E; del Río J; González-Muñiz R
Bioorg Med Chem Lett; 1999 Jan; 9(1):43-8. PubMed ID: 9990454
[TBL] [Abstract][Full Text] [Related]
18. Characterization of two novel cholecystokinin tetrapeptide (30-33) analogues, A-71623 and A-70874, that exhibit high potency and selectivity for cholecystokinin-A receptors.
Lin CW; Shiosaki K; Miller TR; Witte DG; Bianchi BR; Wolfram CA; Kopecka H; Craig R; Wagenaar F; Nadzan AM
Mol Pharmacol; 1991 Mar; 39(3):346-51. PubMed ID: 1706470
[TBL] [Abstract][Full Text] [Related]
19. Biological activity of analogues of YM022. Novel (3-amino substituted phenyl)urea derivatives of 1,4-benzodiazepin-2-one as gastrin/cholecystokinin-B receptor antagonists.
Satoh M; Okamoto Y; Koshio H; Ohta M; Nishida A; Akuzawa S; Miyata K; Mase T; Semple G
Chem Pharm Bull (Tokyo); 1996 Jul; 44(7):1412-4. PubMed ID: 8706146
[TBL] [Abstract][Full Text] [Related]
20. Cholecystokinin-B receptor ligands of the dipeptoid series act as agonists on rat stomach histidine decarboxylase.
Ding XQ; Chen D; Håkanson R
Gastroenterology; 1995 Oct; 109(4):1181-7. PubMed ID: 7557084
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
